United KingdomA 2005 study published in Nature suggested that intranasal oxytocin might increase trust in humans. Subsequent research yielded mixed results, with concerns over methodology and sample size. A new study, published in PNAS, involved 359 men with low trust dispositions. Participants were given either oxytocin or a placebo and then played a trust game with anonymous partners. Men receiving oxytocin entrusted approximately 15% more money than those in the placebo group. When combined with prior research involving 578 men, the pooled analysis showed a 17% increase in trusting behavior. The study confirmed a selective effect of oxytocin on low-trust individuals but did not show a general trust-enhancing effect across all people.
Bias read (Center): The article presents scientific findings without overt ideological framing. It discusses the effects of oxytocin on trust behavior in a controlled experimental setting, focusing on statistical outcomes and methodological considerations. There is no evident political agenda or biased interpretation,
Why factuality (75): The article accurately mentions the 2005 study by Ernst Fehr published in Nature, and the recent study involving 359 men with low trust disposition. However, it lacks specific details about the methodology of the original 2005 study and only briefly references later studies without citing them direc
Why objectivity (70): The article presents the information in a mostly neutral tone, though it implies a positive outcome for oxytocin by stating 'study confirms trust-boosting effect.' This slight emphasis on confirmation might suggest a subtle bias toward the study's findings.
%3Aquality(80)%2Foutremer%252F2026%252F09%252F08%252F6a9fbb92d817b917611415.jpg&w=3840&q=75&output=webp&we)
